Format

Send to

Choose Destination
Cutan Ocul Toxicol. 2017 Jun;36(2):201-202. doi: 10.1080/15569527.2016.1211670. Epub 2016 Aug 11.

A case of bullous pemphigoid ınduced by vildagliptin.

Author information

1
a Department of Dermatology , Dışkapı Yıldırım Beyazıt Education and Research Hospital , Ankara , Turkey.
2
b Department of Pathology , and.
3
c Department of Dermatology , Faculty of Medicine, Hacettepe University , Ankara , Turkey.

Abstract

Bullous pemfigoid (BP), an autoimmune disorder, can also be induced by some medications. Vildagliptin is a new drug used to treat diabetes mellitus (DM). Recently, a few cases of vildagliptin-induced BP have been described in the literature. We report a patient with BP in which vildagliptin was thought to be as a possible causative agent. The awareness of BP development risk during gliptin therapy can prevent unnecessary usage of systemic drugs with serious side effects.

KEYWORDS:

Bullous pemphigoid; gliptins; vildagliptin

PMID:
27460861
DOI:
10.1080/15569527.2016.1211670
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center